drugset / Trial / NCT01748643

CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity

NCT01748643

RandomizedParallel-groupTriple-blindSupportive care

Summary

The purpose of this study is to investigate if a deep neuromuscular block with a continuous infusion of rocuronium titrated to a post-tetanic count (PTC) of 1-2 responses combined with reversal of neuromuscular blockade with sugammadex results in improved surgical conditions for the surgeon and/or improved post-operative respiratory function for the patients as compared to a standard technique with an intubation dose of rocuronium and top-ups as needed to maintain a neuromuscular blockade with a train of four (TOF) count of 1-2 and reversal of neuromuscular blockade with neostigmine/glycopyrrolate. Furthermore, we want to investigate the effect of pneumoperitoneum, and NMB with rocuronium and reversal with sugammadex or neostigmine/glycopyrrolate on cerebral tissue oxygenation.

Timeline

Start
2013-04
Primary completion
2015-01
Completion
2015-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glycopyrrolate Small molecule 10 ug/kg
Comparator Neostigmine Other / unclassified 50 ug/kg
Subject Rocuronium Other / unclassified 0.6 mg/kg
Subject Rocuronium Other / unclassified 10 mg
Subject Sugammadex Other / unclassified 4 mg/kg

Indications